DSM-Firmenich AG

ENXTAM:DSFIR Stock Report

Market Cap: €26.0b

DSM-Firmenich Past Earnings Performance

Past criteria checks 0/6

DSM-Firmenich's earnings have been declining at an average annual rate of -40.9%, while the Chemicals industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 6.5% per year.

Key information

-40.9%

Earnings growth rate

-38.7%

EPS growth rate

Chemicals Industry Growth1.6%
Revenue growth rate6.5%
Return on equity-0.8%
Net Margin-1.5%
Next Earnings Update13 Feb 2025

Recent past performance updates

Recent updates

Estimating The Fair Value Of DSM-Firmenich AG (AMS:DSFIR)

Dec 13
Estimating The Fair Value Of DSM-Firmenich AG (AMS:DSFIR)

We Think DSM-Firmenich (AMS:DSFIR) Has A Fair Chunk Of Debt

Oct 20
We Think DSM-Firmenich (AMS:DSFIR) Has A Fair Chunk Of Debt

DSM-Firmenich AG's (AMS:DSFIR) Popularity With Investors Is Under Threat From Overpricing

Sep 23
DSM-Firmenich AG's (AMS:DSFIR) Popularity With Investors Is Under Threat From Overpricing

A Look At The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)

Aug 28
A Look At The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)

DSM-Firmenich AG's (AMS:DSFIR) Shareholders Might Be Looking For Exit

Jun 20
DSM-Firmenich AG's (AMS:DSFIR) Shareholders Might Be Looking For Exit

Calculating The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)

May 24
Calculating The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)

Here's Why DSM-Firmenich (AMS:DSFIR) Can Afford Some Debt

Apr 27
Here's Why DSM-Firmenich (AMS:DSFIR) Can Afford Some Debt

DSM-Firmenich AG (AMS:DSFIR) Shares Could Be 31% Below Their Intrinsic Value Estimate

Feb 18
DSM-Firmenich AG (AMS:DSFIR) Shares Could Be 31% Below Their Intrinsic Value Estimate

DSM-Firmenich AG's (AMS:DSFIR) Share Price Could Signal Some Risk

Dec 24
DSM-Firmenich AG's (AMS:DSFIR) Share Price Could Signal Some Risk

Revenue & Expenses Breakdown

How DSM-Firmenich makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ENXTAM:DSFIR Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2412,455-1902,535652
31 Mar 2411,541-4242,535652
31 Dec 2310,627-6582,535652
30 Sep 239,686-4561,772295
30 Jun 238,745-2541,772295
31 Mar 238,5681001,772295
31 Dec 228,3904541,772295
30 Sep 229,582837895162
30 Jun 227,8678231,649274
31 Mar 227,5688221,649274
31 Dec 217,2698201,649274
30 Sep 217,9556602,517560
30 Jun 217,5584931,622398
31 Mar 217,5724231,622398
31 Dec 208,1064481,622398
30 Sep 207,9605101,639295
30 Jun 208,0345571,639295
31 Mar 209,0117221,795349
31 Dec 197,9986751,639295
30 Sep 198,2728201,839348
30 Jun 198,5027941,839348
31 Mar 199,1249341,839348
31 Dec 189,2671,0691,839348
30 Sep 189,2359841,753334
30 Jun 189,1062,0821,753334
31 Mar 188,9081,9421,753334
31 Dec 178,6321,7611,753334
30 Sep 178,4711,6761,694309
30 Jun 178,3337381,694309
31 Mar 178,1667111,694309
31 Dec 167,9206451,694309
30 Sep 167,8315881,605332
30 Jun 167,7782741,605332
31 Mar 167,7492141,605332
31 Dec 157,7221741,605332
30 Sep 157,607661,382304
30 Jun 157,4561141,382304
31 Mar 157,2451151,382304
31 Dec 147,0511231,382304
30 Sep 147,4151121,430340
30 Jun 147,8341381,430340
31 Mar 148,3621821,430340
31 Dec 138,8582521,430340

Quality Earnings: DSFIR is currently unprofitable.

Growing Profit Margin: DSFIR is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: DSFIR is unprofitable, and losses have increased over the past 5 years at a rate of 40.9% per year.

Accelerating Growth: Unable to compare DSFIR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DSFIR is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-4.7%).

Return on Equity

High ROE: DSFIR has a negative Return on Equity (-0.78%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 19:06
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DSM-Firmenich AG is covered by 62 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mutlu GundoganABN AMRO Bank N.V.
Martin SchneeAlphaValue
Volker BosseBaader Helvea Equity Research